NASDAQ:ZNTL

Zentalis Pharmaceuticals, Inc.

Stock

USD

Last Close

1.30

06/11 21:01

Market Cap

279.79M

Beta: 1.83

Volume Today

680.48K

Avg: 602.77K

PE Ratio

−2.91

PFCF: −3.94

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-23.43M -	-46.38M 97.93%	-118.55M 155.61%	-166.09M 40.11%	-237.11M 42.76%	-292.19M 23.23%
depreciation and amortization	51K -	111K 117.65%	160K 44.14%	544K 240%	1.43M 162.13%	1.39M 2.59%
deferred income tax	2.37M -	7.78M 228.79%	17K 99.78%	-2.46M 14,582.35%	-769K 68.77%	-853K 10.92%
stock based compensation	308K -	617K 100.32%	23.15M 3,651.38%	35.74M 54.40%	46.84M 31.07%	54.82M 17.04%
change in working capital	-1.18M -	6.51M 652.38%	7.84M 20.55%	16.56M 111.08%	13.25M 19.96%	5.86M 55.75%
accounts receivables	-254K -	777K 405.91%	-277K 135.65%	413K 249.10%
inventory	-1.86M -	-1.51M 18.97%	-5.52M 265.98%	881K 115.96%
accounts payables	977K -	7.12M 629.07%	14.31M 100.86%	13.92M 2.73%	15.53M 11.58%	10.92M 29.68%
other working capital	-40K -	115K 387.50%	-667K 680%	1.35M 301.95%	-2.27M 268.89%	-5.05M 122.20%
other non cash items	-2.37M -	-7.78M 228.79%	556K 107.15%	-38.38M 7,002.16%	12.61M 132.87%	23.15M 83.52%
net cash provided by operating activities	-24.25M -	-39.14M 61.41%	-86.83M 121.81%	-154.09M 77.48%	-163.75M 6.27%	-207.82M 26.91%
investments in property plant and equipment	-227K -	-352K 55.07%	-758K 115.34%	-6.11M 705.67%	-2.55M 58.28%	-583K 77.12%
acquisitions net			18.42M -	-14.32M 177.72%	111.63K 100.78%
purchases of investments			-400.98M -	-363.51M 9.35%	-533.16M 46.67%	-549.18M 3.00%
sales maturities of investments			116.91M -	365.82M 212.91%	421.53M 15.23%	505.31M 19.87%
other investing activites			-18.42M -		-111.63K -
net cash used for investing activites	-227K -	-352K 55.07%	-284.83M 80,818.18%	-18.11M 93.64%	-114.18M 530.31%	-44.46M 61.06%
debt repayment
common stock issued	16K -	81.83M 511,337.50%	327.79M 300.57%	179.67M 45.19%	261.04M 45.29%	237.30M 9.09%
common stock repurchased				-1.15K -
dividends paid
other financing activites	9.46M -	-46K 100.49%	32.65M 71,082.61%	-1.14M 103.51%
net cash used provided by financing activities	9.47M -	81.83M 763.91%	360.44M 340.47%	178.52M 50.47%	261.04M 46.23%	237.30M 9.09%
effect of forex changes on cash						-54K -
net change in cash	-15.01M -	42.34M 382.12%	-11.22M 126.50%	6.31M 156.28%	-16.89M 367.51%	-15.03M 11.00%
cash at beginning of period	40.16M -	25.15M 37.37%	67.49M 168.30%	56.27M 16.62%	62.58M 11.22%	43.07M 31.18%
cash at end of period	25.15M -	67.49M 168.30%	56.27M 16.62%	62.58M 11.22%	45.70M 26.98%	28.04M 38.64%
operating cash flow	-24.25M -	-39.14M 61.41%	-86.83M 121.81%	-154.09M 77.48%	-163.75M 6.27%	-207.82M 26.91%
capital expenditure	-227K -	-352K 55.07%	-758K 115.34%	-6.11M 705.67%	-2.55M 58.28%	-583K 77.12%
free cash flow	-24.48M -	-39.49M 61.35%	-87.58M 121.76%	-160.20M 82.91%	-166.30M 3.81%	-208.41M 25.32%

All numbers in USD (except ratios and percentages)